STOCK TITAN

ArcWest Exploration Inc. Grants Stock Options

ArcWest Exploration (symbol SJRNF) granted 2,175,000 stock options to certain directors, officers, employees and consultants at an exercise price of $0.10 per share, exercisable for five years.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

ArcWest Exploration (symbol SJRNF) granted 2,175,000 stock options to certain directors, officers, employees and consultants at an exercise price of $0.10 per share, exercisable for five years.

The options are subject to vesting provisions, with a portion vesting immediately and the remainder vesting every six months.

Loading...
Loading translation...
Argus Apr 30 session
-9.09% close to close Open Argus
Details

News Market Reaction – SJRNF

On Apr 30, the first trading day after this news, SJRNF closed 9.09% below the previous close.

Data tracked by StockTitan Argus for the Apr 30 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - ArcWest Exploration Inc. (TSXV: AWX) ("ArcWest" or the "Company") announces that it has granted a total of 2,175,000 stock options to certain directors, officers, employees and consultants to the Company, entitling them to purchase one common share for each option held at a price of $0.10 per share and valid for a period of five years. The options are subject to vesting provisions whereas ¼ of the Options will vest immediately upon grant and ¼ every six months thereafter.

Signed
"Tyler Ruks"

Tyler Ruks, Chief Executive Officer and President and Director

For further information please contact: Tyler Ruks, Telephone: 1 (604) 638 3695, email: info@arcwestexploration.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the accuracy or adequacy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290548

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ArcWest Exploration (SJRNF) announce on March 30, 2026 about stock options?

ArcWest granted 2,175,000 stock options exercisable at $0.10 for five years. According to ArcWest, the options were issued to certain directors, officers, employees and consultants and are subject to vesting provisions with staged vesting every six months.

Who is eligible for the 2,175,000 stock options announced by ArcWest (SJRNF)?

The options were granted to certain directors, officers, employees and consultants. According to ArcWest, those groups may exercise options at $0.10 per share during the five-year term subject to the stated vesting schedule.

What is the exercise price and term for the ArcWest Exploration (SJRNF) options granted March 30, 2026?

Each option entitles the holder to purchase one share at an exercise price of $0.10, valid for five years. According to ArcWest, the options follow standard exercise terms and are governed by the company’s option plan and vesting provisions.

How does the vesting schedule for ArcWest (SJRNF) options work as of March 30, 2026?

A portion of the options vests immediately, with the remainder vesting in stages every six months. According to ArcWest, the grants include immediate vesting for part of the award and scheduled vesting thereafter.

Will the ArcWest (SJRNF) option grant likely dilute existing shareholders?

The grant could increase potential share dilution if options are exercised, depending on outstanding share count and exercise activity. According to ArcWest, 2,175,000 options were issued at $0.10; dilution impact depends on total issued common shares.

Keep reading